Rybelsus 3 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FP5W7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,605
Award facts
- Contract value 100% obligated
- $25,605.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,605.04 to AmerisourceBergen Drug Corp for the supply of Rybelsus 3 mg tablets in packages of 30 units. This competitive delivery order, with a firm fixed-price structure, was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract performs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a non-set-aside award. Rybelsus is an oral semaglutide product used in diabetes management, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement requirements to support military healthcare systems.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to military healthcare programs and affiliated government healthcare systems worldwide. The company's successful track record in fulfilling federal medical procurement requirements through competitive awards demonstrates its capability to meet the Defense Logistics Agency's critical pharmaceutical supply needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FP5W7?
SPE2DB25FP5W7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FP5W7 worth?
The government has obligated $25,605 on SPE2DB25FP5W7.
Is contract SPE2DB25FP5W7 an order under another contract?
Yes. SPE2DB25FP5W7 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP5W7 competed?
The extent of competition for SPE2DB25FP5W7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award